Cost of tuberculosis treatment halved in deal to permit generic versions
Johnson & Johnson’s year-long deal on life-saving drug bedaquiline is seen as critical move in campaign against diseaseThe cost of a crucial tuberculosis treatment has been halved after an agreement was made to allow the sale of generic versions of the... #press
?width=140&quality=85&auto=format&fit=max&s=8e20f61b9b3827584479c56471f1e18e